View in EDS HTML Full Text PDF Full Text

De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer.

Saved in:
Bibliographic Details
Title: De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer.
Authors: Ahmed A; Division of Tumor Immunology and Tumor Immunotherapy, German Cancer Research Center (DKFZ), Helmholtz-Institute for Translational Oncology (HI-TRON), Mainz, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Halama N; Division of Tumor Immunology and Tumor Immunotherapy, German Cancer Research Center (DKFZ), Helmholtz-Institute for Translational Oncology (HI-TRON), Mainz, Germany. niels.halama@dkfz.de.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes-Gutenberg-University of Mainz, Mainz, Germany. niels.halama@dkfz.de.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 May 26; Vol. 10 (1), pp. 173. Date of Electronic Publication: 2025 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40414898
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ahmed+A%22">Ahmed A</searchLink>; Division of Tumor Immunology and Tumor Immunotherapy, German Cancer Research Center (DKFZ), Helmholtz-Institute for Translational Oncology (HI-TRON), Mainz, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Springfeld+C%22">Springfeld C</searchLink>; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Halama+N%22">Halama N</searchLink>; Division of Tumor Immunology and Tumor Immunotherapy, German Cancer Research Center (DKFZ), Helmholtz-Institute for Translational Oncology (HI-TRON), Mainz, Germany. niels.halama@dkfz.de.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes-Gutenberg-University of Mainz, Mainz, Germany. niels.halama@dkfz.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2025 May 26; Vol. 10 (1), pp. 173. <i>Date of Electronic Publication: </i>2025 May 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40414898
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41392-025-02260-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 173
    Titles:
      – TitleFull: De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ahmed A
      – PersonEntity:
          Name:
            NameFull: Springfeld C
      – PersonEntity:
          Name:
            NameFull: Halama N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 05
              Text: 2025 May 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-3635
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Signal transduction and targeted therapy
              Type: main
ResultId 1